ASX vs MSFT

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a high valuation (P/E 38.78, Price/Book 8.44) despite solid recent earnings growth and strong 5-year price performance. While profitability and growth metrics are favorable, weak technical trend and inconsistent earnings surprises raise caution. The Graham Number of $5.08 suggests significant overvaluation, though growth-based intrinsic value of $11.15 supports a higher fair value.

Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.